# Ameren Corporation (AEE) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Utilities / Electric Utilities. Price $106.47, market value $29.5 billion.

## Valuation
- **P/E (trailing): 18.8×** (5-yr avg 18.5×, 3-yr avg 17.7×). Ameren Corporation trades at 18.8× trailing earnings, close to its own five-year average of 18.5×. The Utilities median in the September 2026 study was 21.2×. Forward P/E is 18.3×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.87**. A PEG of 0.87 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 3.4×**. Each dollar of revenue is priced at 3.4×.
- **Price / book: 2.2×**. The shares trade at 2.2× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 12.7×**. Enterprise value is 12.7× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: -4.7%** (5-yr avg -6.0%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.
- **Earnings yield: 5.3%**. The inverse of the P/E: 5.3% of the price is earned each year.

## Profitability
- **Operating margin: 24.9%**. 24.9% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 16.6%**. 16.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 10.9%**. 10.9% on shareholders' equity is solid.
- **Return on invested capital: 5.3%**. Return on all capital, debt included, is 5.3%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 3.2%**. Each dollar of assets produces 3.2% of profit.

## Growth
- **Revenue growth (1 yr): 15.4%** (3-yr 3.4%/yr, 5-yr 8.7%/yr). Revenue grew 15.4% over the last year, against 8.7% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 21.0%** (3-yr 8.9%/yr, 5-yr 8.9%/yr). Earnings per share rose 21.0%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 1.43**. Debt is 1.43 times equity, a leveraged balance sheet, which is normal for utilities.
- **Net debt / EBITDA: 5.0×**. It would take 5.0 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 2.82%** ($2.92 per share, trailing). Ameren Corporation yields 2.82%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 53%**. 53% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 8**. 8 straight years of increases.
- **Dividend growth (5 yr): 7.3%/yr** (1-yr 6.0%). The dividend has grown 7.3% a year over five years.

## Analyst view
- **Analyst consensus: buy** (15 analysts). 15 analysts cover Ameren Corporation; the consensus is buy, with an average price target of $120.40 (+13% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 8.5%** (YTD 8.1%, 3-mo -1.9%). The shares are up 8.5% over twelve months including dividends.
- **From 52-week high: -10.0%** (10.3% above the low). Trading 10% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 42**. An RSI of 42 is neutral.
- **Beta (1 yr): -0.08** (volatility 17%). Beta of -0.08 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=AEE · Page: https://foliofundamentals.com/stocks/aee

Not investment advice.